FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35819811000001103: Rubraca 250mg tablets (Clovis Oncology UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
109990801000001117 Rubraca 250mg tablets (Clovis Oncology UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109990901000001111 Rubraca 250mg tablets (Clovis Oncology UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Is a Rucaparib 250mg tablets true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has specific active ingredient Rucaparib camsilate true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rucaparib true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Is a Rubraca true Inferred relationship Existential restriction modifier
Rubraca 250mg tablets (Clovis Oncology UK Ltd) Has active ingredient Rucaparib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rubraca 250mg tablets (Clovis Oncology UK Ltd) 60 tablet Has AMP True Rubraca 250mg tablets (Clovis Oncology UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start